Saal, Stuart D

Publications

Sort by

Co-Author Network

selected publications

Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2020 Academic Article GET IT
Times cited: 60
Fulminant and fatal encephalitis caused by Acanthamoeba in a kidney transplant recipient: case report and literature review. Transplant infectious disease : an official journal of the Transplantation Society. 2013 Review GET IT
Times cited: 30
Excellent outcomes with expanded criteria donor kidneys: the role of the recipient's age. Clinical transplants. 2013 Academic Article GET IT
Sublingual tacrolimus: a pharmacokinetic evaluation pilot study. Pharmacotherapy. 2013 Academic Article GET IT
Times cited: 19
Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient. 2011 GET IT
Times cited: 4
Deceased-donor kidney transplantation: improvement in long-term survival. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2010 Academic Article GET IT
Times cited: 32
Modulation of antibody response in a sensitized patient with ongoing antibody-mediated injury. 2009 GET IT
Use of bortezomib for prevention and treatment of rejection in sensitized patients. 2009 GET IT
Times cited: 4
Neutralization of endotoxin by a phospholipid emulsion in healthy volunteers. The Journal of infectious diseases. 2005 Academic Article GET IT
Times cited: 32
A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. Journal of lipid research. 2003 Academic Article GET IT
Times cited: 110
Cholesterol and interleukin-6 concentrations relate to outcomes in burn-injured patients. The Journal of burn care & rehabilitation. 2003 Academic Article GET IT
Times cited: 21
Safety and pharmacokinetics of an endotoxin-binding phospholipid emulsion. The Annals of pharmacotherapy. 2003 Academic Article GET IT
Times cited: 13
Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis. American journal of physiology. Regulatory, integrative and comparative physiology. 2002 Academic Article GET IT
Times cited: 36
Effect of administration of a phospholipid emulsion on the initial response of horses administered endotoxin. American journal of veterinary research. 2002 Academic Article GET IT
Times cited: 31
LDL Apheresis: an effective and safe treatment for refractory hypercholesterolemia. Cardiovascular drug reviews. 2002 Review GET IT
Times cited: 20
Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients. Clinical nephrology. 2001 Academic Article GET IT
Times cited: 48
Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Critical care medicine. 2001 Academic Article GET IT
Times cited: 152
Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group. The American journal of cardiology. 1998 Academic Article GET IT
Times cited: 101
Clinical experience and future directions for low-density lipoprotein apheresis in the United States. Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis. 1997 Review GET IT
Times cited: 7
Current status of low density lipoprotein-apheresis for the therapy of severe hyperlipidemia. Current opinion in lipidology. 1996 Review GET IT
Times cited: 28
Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Critical care medicine. 1996 Academic Article GET IT
Times cited: 151
Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy. Journal of clinical apheresis. 1996 Review GET IT
Times cited: 10
Advances in LDL-apheresis for the treatment of severe hypercholesterolemia. Current opinion in lipidology. 1994 Review GET IT
Times cited: 33
Immunoadsorption and dextran sulfate cellulose LDL-apheresis for severe hypercholesterolemia: the Rogosin Institute experience 1982-1992. Transfusion science. 1993 Academic Article GET IT
Times cited: 4
Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols. Transplantation. 1993 Academic Article GET IT
Times cited: 43
Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patients. Transfusion. 1991 Academic Article GET IT
Times cited: 13
Extracorporeal LDL cholesterol removal: role of LDL-pheresis in combination with other hypolipidemic therapy to regress vascular disease. The American journal of medicine. 1989 Review GET IT
Times cited: 5
A rationale for setting target plasma lipid levels to reverse atherosclerosis. Beitrage zur Infusionstherapie = Contributions to infusion therapy. 1988 Review GET IT
Times cited: 1
Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura. Transfusion. 1988 Academic Article GET IT
Times cited: 25
Extracorporeal lipid extraction. ASAIO transactions. 1987 Academic Article GET IT
Times cited: 1
Removal of low-density lipoproteins in patients by extracorporeal immunoadsorption. The American journal of medicine. 1986 Academic Article GET IT
Times cited: 61
Plasma high density lipoprotein is increased in man when low density lipoprotein (LDL) is lowered by LDL-pheresis. Proceedings of the National Academy of Sciences of the United States of America. 1986 Academic Article GET IT
Times cited: 31
Plasmapheresis in five dogs with systemic immune-mediated disease. 1985 GET IT
Times cited: 27
Perfusion of plasma over Staphylococcus aureus: release of bacterial products is related to regression of tumor. Journal of biological response modifiers. 1984 Academic Article GET IT
Times cited: 4
Protein A-independent tumoricidal responses in dogs after extracorporeal perfusion of plasma over Staphylococcus aureus. Journal of the National Cancer Institute. 1983 Academic Article GET IT
Times cited: 28
Plasmapheresis in a patient with angioimmunoblastic lymphadenopathy. Improvement in clinical and immunologic abnormalities. 1983 GET IT
Times cited: 5
Plasmapheresis-immunoadsorption for treatment of systemic lupus erythematosus in a dog. 1983 GET IT
Times cited: 13
Reversible "end-stage" lupus nephritis. Analysis of patients able to discontinue dialysis. The American journal of medicine. 1983 Academic Article GET IT
Times cited: 30
Natural history of cadaveric kidney transplants in the absence of early acute rejection. Nephron. 1983 Academic Article GET IT
Times cited: 3
Post-partum hemolytic uremic syndrome: treatment with plasma exchange. 1983 GET IT
Times cited: 8
Extracorporeal modification of plasma and whole blood. Progress in clinical and biological research. 1982 Academic Article GET IT
Declining transplantability of prospective kidney transplant recipients. JAMA. 1981 Academic Article GET IT
Times cited: 21
Plasmapheresis in the prevention and treatment of rapidly progressive renal disease. Clinical and experimental dialysis and apheresis. 1981 Review GET IT
Times cited: 1
Kidney transplantation; use of gamma globulin as an immunosuppressive agent. New York state journal of medicine. 1980 Academic Article GET IT
Times cited: 2
Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis and rheumatism. 1980 Academic Article GET IT
Times cited: 327
Carcinoembryonic antigen elevation in renal failure. Annals of internal medicine. 1979 Academic Article GET IT
Times cited: 14
Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. 1979 GET IT
Times cited: 152
Improved survival-rates in presensitised recipients of kidney transplants by immunosuppression with maternal-source gamma-globulin. Lancet (London, England). 1978 Academic Article GET IT
Times cited: 6
Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. 1977 GET IT
Times cited: 274
Renal transplantation between HLA identical siblings. Comparison with transplants from HLA semi-identical related donors. The New England journal of medicine. 1977 Academic Article GET IT
Times cited: 16
Biologic immunosuppression in renal transplantation using retroplacental (maternal) source gamma globulin. Transplantation proceedings. 1977 Academic Article GET IT
Times cited: 2
Pruritus in dialysis patients treated with parenteral lidocaine. The New England journal of medicine. 1977 Academic Article GET IT
Times cited: 53
Retroplacental serum factors and passive enhancement. Transplantation proceedings. 1976 Academic Article GET IT
Times cited: 6
Improved renal allograft survival using the mixed lymphocyte culture for selection of nonidentical living related donors. Transactions - American Society for Artificial Internal Organs. 1975 Academic Article GET IT
Times cited: 3

more ...

less ...

Background

education and training

M.D., New York Medical College 1971
B.S., Hobart and William Smith Colleges 1967

Contact

full name

Stuart D Saal

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Stuart D Saal Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

webpage